Categories
Carrigent
About CRO
Carrigent is an advanced vector technology Contract Research Organization (CRO) dedicated to transforming therapeutic delivery. Our mission is to overcome the traditional challenges of high cost, limited targeting specificity, and restricted payload capacity associated with conventional viral vectors.
With proprietary technologies and a deep scientific foundation, Carrigent delivers innovative viral and non-viral platforms to biotech and pharmaceutical partners developing gene and cell therapies, biologics, and beyond.
Headquartered in Covina, California, Carrigent partners with teams across discovery, preclinical, and translational research to provide scalable, efficient, and targeted delivery solutions.
Why Choose Carrigent?
Next-Gen Innovation: We offer the CARGO™ Precision Targeting System—a patent-pending, non-viral delivery platform designed for unmatched payload capacity, cell specificity, and low immunogenicity.
Integrated Expertise: From gene-edited cell line creation to viral vector process development and analytics, we support every step of your delivery strategy with technical precision.
Platform Scalability: Carrigent supports small-scale feasibility through to 200L preclinical production, ensuring continuity as your program grows. When you need GMP production we can seamlessly align with our partners to transfer your process.
Flexible Collaboration: Whether you need exclusive tech licensing, standalone services, or full project support, Carrigent adapts to your needs.
Scientific Rigor: Our team combines deep molecular expertise with proprietary tools to deliver reproducible, high-yield outcomes tailored to therapeutic demands.
Technology & Expertise
CARGO™ Precision Targeting System Carrigent’s flagship, patent-pending non-viral delivery platform enables: Delivery of RNA, DNA, or protein payloads High specificity to target cell types Transient or long-term expression Unrestricted cargo capacity Low immunogenicity and dose requirements Viral Vector Platforms Carrigent provides full design and customization for: Lentivirus, Retrovirus, Adeno-associated virus (AAV), Adenovirus, Herpes simplex virus (HSV) and more Cell Line Engineering and Gene Editing Gene-specific tiling libraries Custom iPSC and disease model development Clone screening, isolation, and validation (NGS, qPCR) Proprietary genome engineering for improved viral yield and stability Analytical and Process Development Packaging ratio optimization Residual DNA and viral copy number quantification Viral labeling and VV-based cell painting Producer cell line generation for stable vector production
Core Services
Preclinical viral vector process development and production (up to 200L). Gene-edited cell line development. Custom viral vector engineering. Viral vector analytics and optimization. Non-viral delivery system development. Diagnostic assay design and biomarker detection
Accreditations & Compliance
Carrigent operates under a rigorous quality management system that ensures high reproducibility, sample and data traceability, and compliance with preclinical regulatory expectations. Our procedures meet the standards required for therapeutic development in gene therapy and related advanced modalities.
